HT
FLNA

HAP Trading’s Filana Therapeutics FLNA Stock Holding History

HAP Trading’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$7.22K Hold
67,100
– – ﹤0.01% 784
2025
Q2 		$5.26K Sell
67,100
-33,800
-33% -$60.1K ﹤0.01% 683
2025
Q1 		$9.46K Buy
100,900
+2,000
+2% +$5.05K ﹤0.01% 615
2024
Q4 		$45K Buy
98,900
+33,900
+52% +$595K ﹤0.01% 478
2024
Q3 		$1.39M Buy
+65,000
New +$1.5M 0.16% 102
2024
Q2 		– Sell
-85,000
Closed -$58.6K – 820
2024
Q1 		$58.6K Sell
85,000
-161,000
-65% -$3.71M 0.01% 411
2023
Q4 		$249K Buy
+246,000
New +$5.2M 0.04% 265
2023
Q3 		– Sell
-16,100
Closed -$14.6K – 1239
2023
Q2 		$14.6K Sell
16,100
-201,500
-93% -$4.85M ﹤0.01% 751
2023
Q1 		$55K Sell
217,600
-81,800
-27% -$2.27M 0.01% 509
2022
Q4 		$820K Buy
299,400
+263,000
+723% +$9.45M 0.08% 211
2022
Q3 		$278K Sell
36,400
-7,400
-17% -$200K 0.02% 498
2022
Q2 		$134K Buy
43,800
+7,300
+20% +$184K 0.01% 820
2022
Q1 		$273K Buy
36,500
+19,800
+119% +$839K 0.01% 737
2021
Q4 		$217K Buy
16,700
+3,400
+26% +$178K 0.01% 991
2021
Q3 		$149K Sell
13,300
-9,700
-42% -$810K ﹤0.01% 1136
2021
Q2 		$524K Sell
23,000
-84,700
-79% -$4.54M 0.02% 630
2021
Q1 		$717K Buy
107,700
+88,900
+473% +$3.5M 0.04% 390
2020
Q4 		$49K Buy
+18,800
New +$168K ﹤0.01% 1408
2020
Q3 		– Sell
-154,400
Closed -$11K – 1820
2020
Q2 		$11K Buy
+154,400
New +$700K ﹤0.01% 1436

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

HAP Trading's FLNA Position: Q4 2021 in Review

HAP Trading sold out of Filana Therapeutics (FLNA) in Q4 2021, closing a stake of 13,848 shares — an estimated $726K sold.

HAP Trading first reported a position in FLNA in Q2 2021 and held it in 2 quarters. The position peaked at $891K in Q2 2021. 171 funds tracked by Wall St. Rank hold FLNA as of Q4 2021.

  • HAP Trading reported no remaining Filana Therapeutics position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 13,848 Filana Therapeutics shares in Q4 2021, an estimated $726K.
  • HAP Trading first reported a position in Filana Therapeutics in Q2 2021 and held it in 2 quarters.
  • HAP Trading's Filana Therapeutics position peaked at $891K in Q2 2021.
  • 171 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.